BJDX - Bluejay Diagnostics, Inc.

1.9
-0.050   -2.632%

Share volume: 197,192
Last Updated: 03-05-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$1.95
-0.05
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
34%
Profitability 35%
Dept financing 29%
Liquidity 50%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-7.32%
1 Month
-43.95%
3 Months
62.39%
6 Months
33.80%
1 Year
-55.40%
2 Year
117.96%
Key data
Stock price
$1.90
P/E Ratio 
0.00
DAY RANGE
$1.84 - $1.98
EPS 
-$9.66
52 WEEK RANGE
$0.63 - $10.20
52 WEEK CHANGE
-$54.65
MARKET CAP 
2.393 M
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-14-2025
BETA 
2.97
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$353,486
AVERAGE 30 VOLUME 
$532,624
Company detail
CEO: Indranil Dey
Region: US
Website: bluejaydx.com
Employees: 9
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Bluejay Diagnostics, Inc. develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis.

Recent news